Author: Cavagna, Lorenzo; Seminari, Elena; Zanframundo, Giovanni; Gregorini, Marilena; Di Matteo, Angela; Rampino, Teresa; Montecucco, Carlomaurizio; Pelenghi, Stefano; Cattadori, Barbara; Pattonieri, Eleonora Francesca; Vitulo, Patrizio; Bertani, Alessandro; Sambataro, Gianluca; Vancheri, Carlo; Biglia, Alessandro; Bozzalla-Cassione, Emanuele; Bonetto, Valentina; Monti, Maria Cristina; Ticozzelli, Elena; Turco, Annalisa; Oggionni, Tiberio; Corsico, Angelo; Bertuccio, Francesco; Zuccaro, Valentina; Codullo, Veronica; Morosini, Monica; Marena, Carlo; Gnecchi, Massimiliano; Pellegrini, Carlo; Meloni, Federica
Title: Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy Cord-id: mb1bircp Document date: 2020_6_30
ID: mb1bircp
Snippet: The role of immunosuppression in SARS-CoV-2-related disease (COVID-19) is a matter of debate. We here describe the course and the outcome of COVID-19 in a cohort of patients undergoing treatment with calcineurin inhibitors. In this monocentric cohort study, data were collected from the COVID-19 outbreak in Italy up to 28 April 2020. Patients were followed at our hospital for solid organ transplantation or systemic rheumatic disorders (RMDs) and were on calcineurin inhibitor (CNI)-based therapy.
Document: The role of immunosuppression in SARS-CoV-2-related disease (COVID-19) is a matter of debate. We here describe the course and the outcome of COVID-19 in a cohort of patients undergoing treatment with calcineurin inhibitors. In this monocentric cohort study, data were collected from the COVID-19 outbreak in Italy up to 28 April 2020. Patients were followed at our hospital for solid organ transplantation or systemic rheumatic disorders (RMDs) and were on calcineurin inhibitor (CNI)-based therapy. Selected patients were referred from the North of Italy. The aim of our study was to evaluate the clinical course of COVID-19 in this setting. We evaluated 385 consecutive patients (220 males, 57%; median age 61 years, IQR 48–69); 331 (86%) received solid organ transplantation and 54 (14%) had a RMD. CNIs were the only immunosuppressant administered in 47 patients (12%). We identified 14 (4%) COVID-19 patients, all transplanted, mainly presenting with fever (86%) and diarrhea (71%). Twelve patients were hospitalized and two of them died, both with severe comorbidities. No patients developed acute respiratory distress syndrome or infectious complications. The surviving 10 patients are now fully recovered. The clinical course of COVID-19 patients on CNIs is generally mild, and the risk of superinfection seems low.
Search related documents:
Co phrase search for related documents- absolute number and acute phase: 1
- absolute number and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- absolute number and lombardy piedmont: 1
- absolute number and lombardy piedmont emilia romagna: 1
- absolute number and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- absolute number and lung cancer: 1, 2
- absolute number and lung disease: 1
- absolute number and lung involvement: 1
- acute ards respiratory distress syndrome and low number: 1
- acute ards respiratory distress syndrome and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute ards respiratory distress syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute ards respiratory distress syndrome and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- acute ards respiratory distress syndrome and lung transplant: 1, 2, 3, 4, 5, 6, 7, 8
- acute ards respiratory distress syndrome and lung transplant patient: 1
- acute ards respiratory distress syndrome and lupus erythematosus: 1, 2, 3, 4, 5, 6, 7
- acute phase and low number: 1, 2
- acute phase and lung cancer: 1, 2, 3, 4, 5, 6, 7
- acute phase and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- acute phase and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9
Co phrase search for related documents, hyperlinks ordered by date